Cogent Biosciences
COGT
COGT
175 hedge funds and large institutions have $949M invested in Cogent Biosciences in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 63 increasing their positions, 46 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1.12% less ownership
Funds ownership: 111.31% → 110.19% (-1.1%)
28% less capital invested
Capital invested by funds: $1.32B → $949M (-$367M)
60% less call options, than puts
Call options by funds: $1.54M | Put options by funds: $3.87M
Holders
175
Holding in Top 10
8
Calls
$1.54M
Puts
$3.87M
Top Buyers
| 1 | +$64.3M | |
| 2 | +$11.4M | |
| 3 | +$7.27M | |
| 4 |
SCM
Superstring Capital Management
New York
|
+$7.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.36M |
Top Sellers
| 1 | -$40M | |
| 2 | -$21.6M | |
| 3 | -$12.1M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$11.2M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$9.93M |